TLSA Earnings — Tiziana Life Sciences Ltd
NASDAQ
Updated
When is TLSA's next earnings date?
Tiziana Life Sciences Ltd (TLSA) has not announced its next earnings date yet. Its most recent earnings report was on Friday, October 16, 2026.
How did TLSA do in its last earnings report?
In its most recent report on Oct 16, 2026, Tiziana Life Sciences Ltd posted EPS of -$0.08 versus the -$0.08 estimate, a miss of 2.3%. The stock's 1-day post-earnings move was -3.8%.
How much does TLSA stock move after earnings?
TLSA beat EPS estimates in 0 of its last 4 reported quarters. Over the last 6 reports the stock moved an average of 3.2% (up or down) in the day after earnings.
About Tiziana Life Sciences Ltd
Tiziana Life Sciences Ltd is a biotechnology firm dedicated to the research and advancement of novel molecular therapies for human ailments, particularly within oncology and immunology. Its flagship immunology program features Foralumab (TZLS-401), a human anti-CD3 monoclonal antibody under development for a range of conditions including Crohn's disease, graft versus host disease, ulcerative colitis, multiple sclerosis, type-1 diabetes, inflammatory bowel disease, psoriasis, and rheumatoid arthritis. Additionally, the company is progressing Milciclib (TZLS-201), a small molecule inhibitor that targets multiple cyclin-dependent, tropomycin receptor, and Src family kinases to suppress abnormal cell growth and cancer progression. Another significant asset is anti-Interleukin 6 receptor (IL6R) mAb (TZLS-501), a fully human monoclonal antibody intended to mitigate IL6-induced inflammation and treat COVID-19 patients. Founded in 1998, Tiziana Life Sciences is based in London, United Kingdom.
Earnings History
| Date | Period | EPS Est. | EPS Act. | Surprise | Revenue | Result | 1D Δ | 1W Δ | 1M Δ |
|---|---|---|---|---|---|---|---|---|---|
| 2026-10-16 | -0.08 | -0.08 | -2.30% | — | ❌ Miss | -3.81% | -4.76% | — | |
| 2026-09-18 | -0.08 | -0.08 | -1.35% | — | ❌ Miss | -6.74% | +7.22% | +8.25% | |
| 2026-05-01 | FY 2025 | -0.13 | -0.16 | -23.08% | $0 | ❌ Miss | +3.73% | +17.91% | +1.49% |
| 2024-05-10 | FY 2023 | — | -0.15 | — | $0 | — | -2.70% | +6.41% | +56.23% |
| 2023-12-29 | H1 2023 | — | -0.05 | — | $0 | — | -1.56% | +7.22% | -5.98% |
| 2023-04-26 | FY 2022 | — | -0.15 | — | $0 | — | -0.45% | -12.47% | -16.49% |
| 2022-08-19 | — | -0.10 | — | — | — | — | — | — | |
| 2021-09-24 | -0.06 | -0.20 | — | — | ❌ Miss | — | — | — |
Showing last 8 quarters.